• Liquid Biopsies Could Help Speed Up Lung Cancer Clinical Trials

    Clinical Research News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.

    Apr 6, 2023

  • Dr. Su Golder on Reporting Adverse Events in Clinical Research

    Clinical Research News | Su Golder, associate professor and senior research fellow in the Department of Health Sciences at the University of York, speaks with the Scope of Things podcast host Deborah Borfitz about adverse event reporting and the challenges that hinder its consistent practice in the health sciences community.

    Apr 4, 2023